Filing Details
- Accession Number:
- 0001628280-23-021962
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-13 16:41:21
- Reporting Period:
- 2023-06-09
- Accepted Time:
- 2023-06-13 16:41:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1534120 | Avalo Therapeutics Inc. | AVTX | Pharmaceutical Preparations (2834) | 450705648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1810417 | Ryan Christopher Sullivan | C/O Avalo Therapeutics, Inc. 540 Gaither Road, Suite 400 Rockville MD 20850 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-09 | 511 | $3.42 | 1,262 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
Billionaire Hedge Funds
